Vertex Pharmaceuticals Inc VRTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:57 PM EDT
417.31quote price arrow down-0.01 (-0.00%)
Volume
437,454
52 week range
309.43 - 448.40
Loading...
  • Open419.48
  • Day High420.67
  • Day Low415.06
  • Prev Close417.32
  • 52 Week High448.40
  • 52 Week High Date01/30/24
  • 52 Week Low309.43
  • 52 Week Low Date03/28/23

Key Stats

  • Market Cap107.794B
  • Shares Out258.31M
  • 10 Day Average Volume0.98M
  • Dividend-
  • Dividend Yield-
  • Beta0.35
  • YTD % Change2.89

KEY STATS

  • Open419.48
  • Day High420.67
  • Day Low415.06
  • Prev Close417.32
  • 52 Week High448.40
  • 52 Week High Date01/30/24
  • 52 Week Low309.43
  • 52 Week Low Date03/28/23
  • Market Cap107.794B
  • Shares Out258.31M
  • 10 Day Average Volume0.98M
  • Dividend-
  • Dividend Yield-
  • Beta0.35
  • YTD % Change2.89

RATIOS/PROFITABILITY

  • EPS (TTM)13.89
  • P/E (TTM)30.04
  • Fwd P/E (NTM)24.89
  • EBITDA (TTM)4.013B
  • ROE (TTM)22.99%
  • Revenue (TTM)9.869B
  • Gross Margin (TTM)87.21%
  • Net Margin (TTM)36.68%
  • Debt To Equity (MRQ)2.14%

EVENTS

  • Earnings Date04/29/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

Small caps will get a tailwind from market broadening, says UBS' Jason Draho
VIDEO3:2803:28
Small caps will get a tailwind from market broadening, says UBS' Jason Draho

Profile

MORE
Vertex Pharmaceuticals Incorporated is a global biotechnology company. The Company is focused on investing in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. It has four approved medicines that treat the underlying cause of cystic fibrosis (CF), and one approved therapy that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT). Its pipeline includes clinical-stage...
Jeffrey Leiden M.D., Ph.D.
Executive Chairman of the Board
Reshma Kewalramani
President, Chief Executive Officer, Director
Stuart Arbuckle
Chief Operating Officer, Executive Vice President
Charles Wagner Jr.
Chief Financial Officer, Executive Vice President
Carmen Bozic M.D.
Executive Vice President - Global Medicines Development and Medical Affairs, Chief Medical Officer
Address
50 Northern Avenue
Boston, MA
02210
United States

Top Peers

SYMBOLLASTCHG%CHG
ZTS
Zoetis Inc
170.82+2.31+1.37%
GILD
Gilead Sciences Inc
73.61+0.60+0.83%
HLN
HALEON PLC
8.54+0.01+0.12%
TAK
Takeda Pharmaceutical Co Ltd
13.85-0.34-2.40%
AMGN
Amgen Inc
285.71-0.59-0.21%